Citation only
via OpenAlex
SIRT1 in metabolic syndrome: Where to target matters
Yu Wang, Cheng Xu, Yan Liang, Paul M. Vanhoutte
Pharmacology & Therapeutics · 2012 · ▲ 51 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.pharmthera.2012.08.009
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Wang, Y., Xu, C., Liang, Y., & Vanhoutte, P.M. (2012). SIRT1 in metabolic syndrome: Where to target matters. <em>Pharmacology & Therapeutics</em>. https://doi.org/10.1016/j.pharmthera.2012.08.009
Vancouver
Wang Y, Xu C, Liang Y, Vanhoutte PM. SIRT1 in metabolic syndrome: Where to target matters. Pharmacology & Therapeutics. 2012. doi:10.1016/j.pharmthera.2012.08.009.
BibTeX
@article{yu2012SIRTin,
title = {SIRT1 in metabolic syndrome: Where to target matters},
author = {Yu Wang and Cheng Xu and Yan Liang and Paul M. Vanhoutte},
journal = {Pharmacology & Therapeutics},
year = {2012},
doi = {10.1016/j.pharmthera.2012.08.009},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Research and Clinical Practice 2007
Citation only
Stroke presentation in Type 2 diabetes and the metabolic syndrome
Life Sciences 2009
Citation only
Oxidative stress and metabolic syndrome
Archives of Pharmacal Research 2013
Citation only
Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy
The Journal of Pediatrics 2007
Citation only
Metabolic Syndrome in Childhood Predicts Adult Metabolic Syndrome and Type 2 Diabetes Mellitus 25 to 30 Years Later
Nature Cell Biology 2009
Open access · OA
STAT3 inhibition of gluconeogenesis is downregulated by SirT1
Nature Reviews Drug Discovery 2016
Preprint · OA